Bill Text

Bill Information


Bill PDF |Add To My Favorites | print page

HR-88 (2023-2024)

SHARE THIS: share this bill in Facebook share this bill in Twitter
HR88:v99#DOCUMENT

Revised  May 06, 2024

CALIFORNIA LEGISLATURE— 2023–2024 REGULAR SESSION

House Resolution
No. 88


Introduced by Assembly Member Boerner
(Coauthors: Assembly Members Addis, Aguiar-Curry, Alanis, Arambula, Bauer-Kahan, Bennett, Berman, Calderon, Juan Carrillo, Wendy Carrillo, Cervantes, Chen, Connolly, Davies, Dixon, Essayli, Flora, Vince Fong, Friedman, Gabriel, Gallagher, Garcia, Gipson, Haney, Hart, Holden, Hoover, Irwin, Jackson, Jones-Sawyer, Lackey, Lowenthal, Maienschein, McCarty, McKinnor, Ortega, Pacheco, Papan, Jim Patterson, Joe Patterson, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Rendon, Reyes, Robert Rivas, Rodriguez, Blanca Rubio, Sanchez, Santiago, Schiavo, Soria, Ta, Valencia, Villapudua, Waldron, Wallis, Ward, Weber, Wicks, Wilson, Wood, and Zbur)

April 03, 2024


Relative to Tardive Dyskinesia Awareness Week.


LEGISLATIVE COUNSEL'S DIGEST


HR 88, as introduced, Boerner.

WHEREAS, Many people with serious mental health conditions, such as bipolar disorder, major depression, schizophrenia, and schizoaffective disorder, or gastrointestinal disorders, including gastroparesis, nausea, and vomiting, may be treated with medications that work as dopamine receptor blocking agents (DRBAs), including antipsychotics and antiemetics; and
WHEREAS, While ongoing treatment with these medications can be necessary, prolonged use can also lead to Tardive Dyskinesia (TD), an involuntary movement disorder that is characterized by uncontrollable, abnormal, and repetitive movements of the face, torso, limbs, fingers, or toes that can impact people physically, socially, and emotionally; and
WHEREAS, It is estimated that TD affects approximately 600,000 people in the United States and approximately 65 percent of people with TD remain undiagnosed, making it important to raise awareness about the symptoms; and
WHEREAS, It is important for people taking these medications be monitored for TD by a health care provider. Regular screening for TD in these patients is recommended by the American Psychiatric Association; and
WHEREAS, Clinical research has led to the approval of treatments for adults with TD by the United States Food and Drug Administration. Recognition and treatment of TD can make a positive impact on the lives of many people experiencing psychotic and mood disorders; and
WHEREAS, Anyone experiencing uncontrollable, abnormal, and repetitive movements should be empowered to consult their health care provider regarding their symptoms to determine appropriate treatment; now, therefore, be it
Resolved by the Assembly of the State of California, That the Assembly proclaims the week of May 6, 2024, as Tardive Dyskinesia Awareness Week in California, and commends the observance of the week to all residents of the state; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
___________________


REVISIONS:
Heading—Line 2.
___________________